US 11,864,554 B2
Tissue preservation system
James L. Cook, Columbia, MO (US); Clark T. Hung, Ardsley, NY (US); Eric Lima, New York, NY (US); and Aaron Stoker, Columbia, MO (US)
Assigned to The Curators of the University of Missouri, Columbia, MO (US); and The Trustees of Columbia University in New York, New York, NY (US)
Filed by The Curators of the University of Missouri, Columbia, MO (US); and The Trustees of Columbia University in the City of New York, New York, NY (US)
Filed on Oct. 17, 2022, as Appl. No. 17/967,598.
Application 14/946,634 is a division of application No. 13/349,534, filed on Jan. 12, 2012, granted, now 9,220,258, issued on Dec. 29, 2015.
Application 17/967,598 is a continuation of application No. 16/562,145, filed on Sep. 5, 2019, granted, now 11,503,823.
Application 16/562,145 is a continuation of application No. 16/022,452, filed on Jun. 28, 2018, granted, now 10,881,098, issued on Jan. 5, 2021.
Application 16/022,452 is a continuation of application No. 14/946,634, filed on Nov. 19, 2015, granted, now 10,039,277, issued on Aug. 7, 2018.
Claims priority of provisional application 61/461,049, filed on Jan. 12, 2011.
Prior Publication US 2023/0131820 A1, Apr. 27, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 1/02 (2006.01)
CPC A01N 1/0226 (2013.01) [A01N 1/021 (2013.01); A01N 1/0242 (2013.01); A01N 1/0263 (2013.01); A01N 1/0284 (2013.01)] 17 Claims
 
1. A process for tendon tissue preservation comprising storing the tendon tissue at room temperature in a container comprising a serum-free culture medium comprising dexamethasone for from about 7 to about 70 days prior to implantation, wherein at least 70% of the cells of said tendon tissue remain viable after said storing compared to the viability of the cells of the tendon tissue at day 0.